The new staging is shown in Table 2, and hopefully it will be used in the next guidelines. Table 1. The ‘old’ FIGO staging for endometrial cancer: it is included here as the currently existing literature is based on this and t would be useful for the reader to take it into account...
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): vi33-vi38.Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and ...
Furthermore, it asserts that patients treated from the disease must be followed-up for late toxicity and possible recurrence.关键词: ESMO Clinical Practice Guideline diagnosis endometrial cancer follow-up treatment DOI: 10.1093/annonc/mdq245 年份: 2010 ...
Although most patients with endometrial cancer are cured with hysterectomy alone, a subset of patients with relatively high-risk disease may benefit from effective adjuvant treatments. Investigators are still attempting to define the indications for and risks and benefits of additional interventions, includ...
To facilitate the formulation of diagnosis and treatment strategies, the Guidelines describe from two persectives: Colorectal Liver Metastasis at Diagnosis and Liver Metastasis after Radical Resection of Colorectal Cancer. 1.2. The routine diagnosis of liver metastasis at the time of diagnosis of ...
While surgery is the first-line treatment for endometrial cancer, some women will need to undergo additional therapies like radiation therapy or chemotherapy based on their risk of cancer recurrence after treatment. This risk of recurrence—defined as low, intermediate, or high—is designated by a ...
for analysis. This is usually done in an outpatient setting. The tissue sample is analysed in a laboratory to determine whether cancer cells are present, and if so, what type of endometrial cancer and grade it is (described further below). Genetic testing may also be done on the cancer ...
The integration of immune-checkpoint inhibitors, specifically the anti-PD-1 antibody pembrolizumab, into chemoradiotherapy has provided a new standard-of-care treatment for patients with high-risk locally advanced cervical cancer (stage III–IVA). The treatment landscape of metastatic, recurrent or persi...
EP: 6.Treatment Choices for Recurrent dMMR Endometrial Cancer EP: 7.HER2-Positive Endometrial Cancer: A Targeted Approach to Treatment EP: 8.Treatment for Recurrent Endometrial Cancer: Chemotherapy or Lenvatinib + Pembrolizumab EP: 9.Endometrial Cancer: Managing Toxicities in Lenvatinib and Pembrolizum...
Van der Zee, A. G. et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.J. Clin. Oncol.26, 884–889 (2008). PubMedGoogle Scholar Rossi, E. C. et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES ...